Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Slavin, TP"'
Autor:
Walker, LC, Marquart, L, Pearson, JF, Wiggins, GAR, O'Mara, TA, Parsons, MT, BCFR, Barrowdale, D, McGuffog, L, Dennis, J, Benitez, J, Slavin, TP, Radice, P, Frost, D, EMBRACE, Godwin, AK, Meindl, A, Schmutzler, RK, GEMO Study Collaborators, Isaacs, C, Peshkin, BN, Caldes, T, Hogervorst, FB, HEBON, Lazaro, C, Jakubowska, A, Montagna, M, KConFab Investigators, Chen, X, Offit, K, Hulick, PJ, Andrulis, IL, Lindblom, A, Nussbaum, RL, Nathanson, KL, Chenevix-Trench, G, Antoniou, AC, Couch, FJ, Spurdle, AB
Genome-wide studies of patients carrying pathogenic variants (mutations) in BRCA1 or BRCA2 have reported strong associations between single-nucleotide polymorphisms (SNPs) and cancer risk. To conduct the first genome-wide association analysis of copy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______109::1c3b1638f6e56a1cd6a13a6359a275a9
https://www.repository.cam.ac.uk/handle/1810/262960
https://www.repository.cam.ac.uk/handle/1810/262960
Autor:
Pfeiler, G, Vigorito, E, Kuchenbaecker, KB, Beesley, J, Adlard, J, Agnarsson, BA, Andrulis, IL, Arun, BK, Barjhoux, L, Belotti, M, Benitez, J, Berger, A, Phelan, CM, Piedmonte, M, Poppe, B, Pujana, MA, Radice, P, Rennert, G, Rodriguez, GC, Rookus, MA, Ross, EA, Bojesen, A, Schmutzler, RK, Simard, J, Singer, CF, Slavin, TP, Soucy, P, Southey, M, Steinemann, D, Stoppa-Lyonnet, D, Sukiennicki, G, Sutter, C, Bonanni, B, Szabo, CI, Tea, MK, Teixeira, MR, Teo, SH, Terry, MB, Thomassen, M, Tibiletti, MG, Tihomirova, L, Tognazzo, S, van Rensburg, EJ, Brewer, C, Varesco, L, Varon-Mateeva, R, Vratimos, A, Weitzel, JN, McGuffog, L, Kirk, J, Toland, AE, Hamann, U, Lindor, N, Ramus, SJ, Caldes, T, Greene, MH, Couch, FJ, Offit, K, Pharoah, PDP, Chenevix-Trench, G, Antoniou, AC, Prokunina-Olsson, L, Caligo, MA, Campbell, I, Chan, SB, Claes, KBM, Cohn, DE, Cook, J, Daly, MB, Damiola, F, Davidson, R, Pauw, AD, Delnatte, C, Diez, O, Domchek, SM, Dumont, M, Durda, K, Dworniczak, B, Easton, DF, Eccles, D, Edwinsdotter Ardnor, C, Eeles, R, Ejlertsen, B, Ellis, S, Evans, G, Feliubadalo, L, Fostira, F, Foulkes, WD, Friedman, E, Frost, D, Gaddam, P, Ganz, PA, Garber, J, Garcia-Barberan, V, Gauthier-Villars, M, Gehrig, A, Gerdes, AM, Giraud, S, Godwin, AK, Goldgar, DE, Hake, CR, Hansen, TVO, Healey, S, Hodgson, S, Hogervorst, FBL, Houdayer, C, Hulick, PJ, Imyanitov, EN, Isaacs, C, Izatt, L, Izquierdo, A, Jacobs, L, Jakubowska, A, Janavicius, R, Jaworska-Bieniek, K, Jensen, UB, John, EM, Vijai, J, Karlan, BY, Kast, K, Investigators, K, Khan, S, Kwong, A, Laitman, Y, Lester, J, Lesueur, F, Liljegren, A, Lubinski, J, Mai, PL, Manoukian, S, Mazoyer, S, Meindl, A, Mensenkamp, AR, Montagna, M, Nathanson, KL, Neuhausen, SL, Nevanlinna, H, Niederacher, D, Olah, E, Olopade, OI, Ong, KR, Osorio, A, Park, SK, Paulsson-Karlsson, Y, Pedersen, IS, Peissel, B, Peterlongo, P
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Universitat Autònoma de Barcelona
Population-based genome wide association studies have identified a locus at 9p22.2 associated with ovarian cancer risk, which also modifies ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. We conducted fine-scale mapping at 9p22.2 to identif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6c9d8e45b54b76540dfebb79122ffc8f
https://ddd.uab.cat/record/254191
https://ddd.uab.cat/record/254191
Publikováno v:
Hereditary Genetics.
De novo terminal deletions of chromosome 15q26.1 are rare occurrences. Deletions of this region have been previously linked to congenital diaphragmatic hernia (CDH) as well as congenital malformations and developmental delay. This article presents a
Autor:
Slavin TP, Wiesner GL
Publikováno v:
Current Opinion in Pediatrics; 2009 Dec, Vol. 21 Issue 6, p717-723, 7p
Autor:
Walker, LC, Marquart, L, Pearson, JF, Wiggins, GAR, O'Mara, TA, Parsons, MT, BCFR, Barrowdale, D, McGuffog, L, Dennis, J, Benitez, J, Slavin, TP, Radice, P, Frost, D, EMBRACE, Godwin, AK, Meindl, A, Schmutzler, RK, GEMO Study Collaborators, Isaacs, C, Peshkin, BN, Caldes, T, Hogervorst, FB, HEBON, Lazaro, C, Jakubowska, A, Montagna, M, KConFab Investigators, Chen, X, Offit, K, Hulick, PJ, Andrulis, IL, Lindblom, A, Nussbaum, RL, Nathanson, KL, Chenevix-Trench, G, Antoniou, AC, Couch, FJ, Spurdle, AB
Genome-wide studies of patients carrying pathogenic variants (mutations) in BRCA1 or BRCA2 have reported strong associations between single-nucleotide polymorphisms (SNPs) and cancer risk. To conduct the first genome-wide association analysis of copy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebea1c47385f73f9d1295a51c5dc1464
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lenz L; Myriad Genetics, Inc., Salt Lake City, UT, USA., Clegg W; Myriad Genetics, Inc., Salt Lake City, UT, USA., Iliev D; Myriad Genetics, Inc., Salt Lake City, UT, USA., Kasten CR; Myriad Genetics, Inc., Salt Lake City, UT, USA., Korman H; Comprehensive Urology, Royal Oak, MI, USA.; Wayne State University, Detroit, MI, USA., Morgan TM; University of Michigan, Ann Arbor, MI, USA., Hafron J; Michigan Institute of Urology, Troy, MI, USA., DeHaan A; Urologic Consultants, Wyoming, MI, USA., Olsson C; Integrated Medical Professionals, Melville, NY, USA., Tutrone RF Jr; Chesapeake Urology, Towson, MD, USA., Richardson T; Wichita Urology, Pratt, KS, USA., Cline K; Regional Urology, Shreveport, LA, USA., Yonover PM; UroPartners, Chicago, IL, USA., Jasper J; Myriad Genetics, Inc., Salt Lake City, UT, USA., Cohen T; Myriad Genetics, Inc., Salt Lake City, UT, USA., Finch R; Myriad Genetics, Inc., Salt Lake City, UT, USA., Slavin TP Jr; Myriad Genetics, Inc., Salt Lake City, UT, USA., Gutin A; Myriad Genetics, Inc., Salt Lake City, UT, USA. agutin@myriad.com.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.
Autor:
Mabey B; Myriad Genetics, Inc., Salt Lake City, UT., Hughes E; Myriad Genetics, Inc., Salt Lake City, UT. Electronic address: ehughes@myriad.com., Kucera M; Myriad Genetics, Inc., Salt Lake City, UT., Simmons T; Myriad Genetics, Inc., Salt Lake City, UT., Hullinger B; Myriad Genetics, Inc., Salt Lake City, UT., Pederson HJ; Cleveland Clinic, Cleveland, OH., Yehia L; Cleveland Clinic, Cleveland, OH., Eng C; Cleveland Clinic, Cleveland, OH., Garber J; Dana-Farber Cancer Institute, Boston, MA., Gary M; Grand View Health, Sellersville, PA., Gordon O; Providence Health, Los Angeles, CA., Klemp JR; The University of Kansas Medical Center, Kansas City, KS., Mukherjee S; Memorial Sloan Kettering Cancer Center, New York, NY., Vijai J; Memorial Sloan Kettering Cancer Center, New York, NY., Offit K; Memorial Sloan Kettering Cancer Center, New York, NY., Olopade OI; University of Chicago, Chicago, IL., Pruthi S; Mayo Clinic, Rochester, MN., Kurian A; Stanford University School of Medicine, Stanford, CA., Robson ME; Memorial Sloan Kettering Cancer Center, New York, NY., Whitworth PW; Nashville Breast Center, Nashville, TN., Pal T; Vanderbilt University Medical Center, Nashville, TN., Ratzel S; Myriad Genetics, Inc., Salt Lake City, UT., Wagner S; Myriad Genetics, Inc., Salt Lake City, UT., Lanchbury JS; Myriad Genetics, Inc., Salt Lake City, UT., Taber KJ; Myriad Genetics, Inc., Salt Lake City, UT., Slavin TP; Myriad Genetics, Inc., Salt Lake City, UT., Gutin A; Myriad Genetics, Inc., Salt Lake City, UT.
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2024 Jul; Vol. 26 (7), pp. 101128. Date of Electronic Publication: 2024 Jun 03.
Autor:
Lenz L; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Neff C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Solimeno C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Cogan ES; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Abramson VG; Vanderbilt University Medical Center, Nashville, TN, USA., Boughey JC; Mayo Clinic, Rochester, MN, USA., Falkson C; University of Rochester Medical Center, Rochester, NY, USA., Goetz MP; Mayo Clinic, Rochester, MN, USA., Ford JM; Stanford University School of Medicine, Stanford, CA, USA., Gradishar WJ; Northwestern University, Chicago, IL, USA., Jankowitz RC; University of Pennsylvania, Philadelphia, PA, USA., Kaklamani VG; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Marcom PK; Duke University, Durham, NC, USA., Richardson AL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Storniolo AM; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA., Tung NM; Beth Israel Deaconess Medical Center, Boston, MA, USA., Vinayak S; University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, 15. AstraZeneca, Seattle, WA, USA., Hodgson DR; AstraZeneca, Cambridge, UK., Lai Z; AstraZeneca, Boston, MA, USA., Dearden S; AstraZeneca, Cambridge, UK., Hennessy BT; Royal College of Surgeons in Ireland, Dublin, Ireland., Mayer EL; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mills GB; Oregon Health & Science University, Portland, OR, USA., Slavin TP; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Gutin A; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Connolly RM; Cancer Research @UCC, University College Cork, Cork, Ireland., Telli ML; Stanford University School of Medicine, Stanford, CA, USA., Stearns V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Lanchbury JS; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Timms KM; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA. ktimms@myriad.com.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Nov; Vol. 202 (1), pp. 191-201. Date of Electronic Publication: 2023 Aug 17.
Autor:
Jones MA; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Timms KM; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Hatcher S; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Cogan ES; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Comeaux MS; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Perry M; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Morris B; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Swedlund B; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Elks CE; Oncology R&D, AstraZeneca, Cambridge, UK., Lao-Sirieix P; Oncology R&D, AstraZeneca, Cambridge, UK., Dearden S; Oncology R&D, AstraZeneca, Cambridge, UK., Egile C; Oncology R&D, AstraZeneca, Cambridge, UK., Brown JS; Oncology R&D, AstraZeneca, Cambridge, UK., Harrington EA; Oncology R&D, AstraZeneca, Cambridge, UK., Hodgson D; Oncology R&D, AstraZeneca, Cambridge, UK., Stern M; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Slavin TP; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Mancini-DiNardo D; Myriad Genetics, Inc, Salt Lake City, Utah, USA.
Publikováno v:
Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2023 Oct; Vol. 62 (10), pp. 589-596. Date of Electronic Publication: 2023 May 24.